Blood-Based Biomarkers for Alzheimer Disease
JAMA · 24.02.2026 · 335 (8) · 663
DOI: 10.1001/jama.2025.26049 ↗Kurz gefasst
Fachartikel in der Zeitschrift JAMA, erschienen am 24.02.2026. Verfasst von Heather E Whitson und 2 weiteren Autor:innen. Beteiligte Einrichtung: Duke Aging Center and Duke/UNC Alzheimer's Disease Research Center, School of Medicine, Duke University, Durham, North Carolina. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 8 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIA NIH HHS.
Themen: Demenz
Abstract (Originalsprache)
This Viewpoint discusses areas of potential harm and actions needed to mitigate risk so that the use of blood-based biomarkers for Alzheimer disease can achieve the intended goal of improving care for all.
Autor:innen und Institutionen
- Duke Aging Center and Duke/UNC Alzheimer's Disease Research Center, School of Medicine, Duke University, Durham, North Carolina.
- Geriatrics Research Education and Clinical Center, Durham VA Medical Center, Durham, North Carolina.
- Department of Medicine, Indiana University School of Medicine, Indianapolis.
- Indiana University Center for Aging Research at the Regenstrief Institute, Indianapolis.
- Department of Epidemiology and Prevention, Wake Forest University School of Medicine, Winston-Salem, North Carolina.
Förderung
- NIA NIH HHS
Zitieren
APA
Whitson, H. E., Fowler, N. R., & Mielke, M. M. (2026). Blood-Based Biomarkers for Alzheimer Disease. JAMA, 335(8), 663. https://doi.org/10.1001/jama.2025.26049
Vancouver
Whitson HE, Fowler NR, Mielke MM. Blood-Based Biomarkers for Alzheimer Disease. JAMA. 2026;335(8):663. doi:10.1001/jama.2025.26049
BibTeX
@article{Whitson2026,
author = {Whitson, Heather E and Fowler, Nicole R and Mielke, Michelle M},
title = {Blood-Based Biomarkers for Alzheimer Disease},
journal = {JAMA},
year = {2026},
volume = {335},
number = {8},
pages = {663},
doi = {10.1001/jama.2025.26049}
}
EUVIMED